No abstract available
Keywords:
COVID-19; SARS-CoV-2; dexamethasone; hyperinflammation; proresolving lipids.
Publication types
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
COVID-19 / immunology
-
COVID-19 Drug Treatment*
-
Dexamethasone / pharmacology*
-
Dexamethasone / therapeutic use
-
Docosahexaenoic Acids / physiology*
-
Fatty Acids, Unsaturated / physiology*
-
Humans
-
Inflammation / drug therapy*
-
SARS-CoV-2*
Substances
-
Fatty Acids, Unsaturated
-
protectin D1
-
resolvin D4
-
Docosahexaenoic Acids
-
Dexamethasone